[go: up one dir, main page]

ES439106A1 - Un procedimiento para la obtencion de preparados vitaminicosen solucion limpia y anhidrida. - Google Patents

Un procedimiento para la obtencion de preparados vitaminicosen solucion limpia y anhidrida.

Info

Publication number
ES439106A1
ES439106A1 ES439106A ES439106A ES439106A1 ES 439106 A1 ES439106 A1 ES 439106A1 ES 439106 A ES439106 A ES 439106A ES 439106 A ES439106 A ES 439106A ES 439106 A1 ES439106 A1 ES 439106A1
Authority
ES
Spain
Prior art keywords
vitamin
stable injectable
vitamin compositions
injectable vitamin
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES439106A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES439106A1 publication Critical patent/ES439106A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES439106A 1975-02-14 1975-07-03 Un procedimiento para la obtencion de preparados vitaminicosen solucion limpia y anhidrida. Expired ES439106A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH189775 1975-02-14

Publications (1)

Publication Number Publication Date
ES439106A1 true ES439106A1 (es) 1977-07-01

Family

ID=4221142

Family Applications (1)

Application Number Title Priority Date Filing Date
ES439106A Expired ES439106A1 (es) 1975-02-14 1975-07-03 Un procedimiento para la obtencion de preparados vitaminicosen solucion limpia y anhidrida.

Country Status (11)

Country Link
US (1) US4075333A (es)
JP (1) JPS603044B2 (es)
BE (1) BE831363A (es)
CA (1) CA1043258A (es)
DE (1) DE2526938C2 (es)
ES (1) ES439106A1 (es)
FR (1) FR2300554A1 (es)
GB (1) GB1471797A (es)
MX (1) MX172916B (es)
NL (1) NL167092C (es)
ZA (1) ZA754011B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
HU185533B (en) * 1982-05-21 1985-02-28 Richter Gedeon Vegyeszet Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンｅ水性製剤
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
KR19990071255A (ko) * 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
WO2002076442A1 (fr) * 2001-03-27 2002-10-03 Santen Pharmaceutical Co., Ltd. Preparation liquide aqueuse stable
AU2002317053B2 (en) * 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
US7081248B2 (en) * 2001-08-03 2006-07-25 Adisseo France S.A.S. Concentrated water-dispersible vitamin compositions
MXPA04005260A (es) * 2001-12-03 2005-03-23 Novacea Inc Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
WO2003049774A1 (en) * 2001-12-13 2003-06-19 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
EP1720551B9 (en) 2004-03-03 2011-09-21 Vital Health Sciences Pty Ltd. Alkaloid formulations
EP1858508A4 (en) * 2005-03-03 2009-01-07 Vital Health Sciences Pty Ltd COMPOUNDS HAVING ANTICANCER PROPERTIES
EP1893159B1 (en) * 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
EP1973547A1 (en) * 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
WO2008000710A1 (en) 2006-06-27 2008-01-03 Akzo Nobel N.V. Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
BR112012024835A2 (pt) 2010-03-30 2016-06-07 Phosphagenics Ltd adesivo de distribuição transdérmica
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
EP3297604B1 (en) * 2015-05-22 2020-07-22 Fresenius Kabi Deutschland GmbH Vitamin a for parenteral administration
US10342775B2 (en) * 2015-05-22 2019-07-09 Fresenius Kabi Deutschland Gmbh Vitamin A for parenteral administration
ES2981002T3 (es) 2015-12-09 2024-10-04 Avecho Biotechnology Ltd Formulación farmacéutica
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
FR1370929A (fr) * 1963-09-06 1964-08-28 Hoffmann La Roche Procédé pour la préparation de compositions vitaminées
US3244595A (en) * 1965-05-07 1966-04-05 Mattox And Moore Inc Composition for administering vitamins a, d, and e
DE2019839A1 (de) * 1969-04-28 1970-11-05 Ferrosan As Stabile,klare,wasserdispergierbare bzw.-verduennbare,Vitamin-A enthaltende Loesung und Verfahren zu ihrer Herstellung
US3639587A (en) * 1969-11-07 1972-02-01 Eastman Kodak Co Medicinal compositions for administration to animals and process for administering same
US3708583A (en) * 1970-04-03 1973-01-02 Vitamin Premixers Of Omaha Inc Stabilized vitamin a additive
NL7012460A (es) * 1970-08-22 1972-02-24
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations

Also Published As

Publication number Publication date
NL167092C (nl) 1981-11-16
FR2300554A1 (fr) 1976-09-10
FR2300554B1 (es) 1979-10-12
US4075333A (en) 1978-02-21
JPS5195123A (en) 1976-08-20
BE831363A (fr) 1976-01-15
JPS603044B2 (ja) 1985-01-25
ZA754011B (en) 1976-09-29
MX172916B (es) 1994-01-20
GB1471797A (en) 1977-04-27
CA1043258A (en) 1978-11-28
NL7508437A (nl) 1976-08-17
NL167092B (nl) 1981-06-16
AU8249875A (en) 1977-01-06
DE2526938C2 (de) 1982-04-22
DE2526938A1 (de) 1976-08-26

Similar Documents

Publication Publication Date Title
ES439106A1 (es) Un procedimiento para la obtencion de preparados vitaminicosen solucion limpia y anhidrida.
ES477172A1 (es) Procedimiento para la preparacion de 9-deoxi-9a-metilen isosteros de pgi2.
ES479271A1 (es) Un procedimiento para la preparacion de compuestos derivados de acido tioetianico.
ES2167326T3 (es) N-acetilglucosaminil-transferasa, gen que la codifica, vectores y huespedes transformados correspondientes y procedimientos para su produccion.
GB835084A (en) Method of continuously casting metals
GB1132636A (en) Improvements in or relating to flame-extinguishing compositions
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
PH15114A (en) Propanone derivatives,and pharmaceutical composition containing this derivative as active ingredient
BG30165A4 (en) Fungicide means and method for fungous fighting
IT1121748B (it) Composizioni con proprieta'deodoranti costituite prevalentemente da derivati cicloesilici di alcooli alifatici
SE427079B (sv) Anvending av vissa biocida 1,10-fenantrolinderivat for att forhindra mikrobiell tillvext i funktionella vetskor, sasom metallbearbetningsvetskor och skervetskor
IT7825483A0 (it) Derivati dell'acido fenossifenossi crotonico e composizione erbicida.
FR2320052A1 (fr) Nouvelles compositions fongicides contenant des derives 1,2,4-triazoliques et des gibberellines
GB1525971A (en) Deodorant composition
ES2093752T3 (es) Complejos de hierro que contienen conalbumina y sus derivados.
GB1513383A (en) Pharmaceutical compositions
GB1487796A (en) Perfuming agents containing sesquiterpenic derivatives
ES448979A1 (es) Procedimiento para la preparacion de nuevas pirrolidinas analogas a prostaglandinas.
GB1480441A (en) Compositions for treating nicotine poisoning
GB1498857A (en) Antidepressant composition
IT7923181A0 (it) Composizioni protettive delle piante contenenti derivati di 1,4-ossaza-spiroidrocarbonio.
GB1514113A (en) Therapeutic compositions containing dimercapto-diethyl ether derivatives
JPS54151925A (en) Nn*1**methoxycarbonylethyl**nn*n**n** disubstituted hydrazinoacetyl**aniline derivative*its manufacture and fungicidal composition containing it as active component
GB1020319A (en) Tobacco manufacture
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970211